-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998448 | Anti-BACE1 Reference Antibody (Genentech anti-BACE1), Anti-BACE1 Reference Antibody (Genentech anti-BACE1), |
|||
| A666679 | Anti-BAFF & IL-17A Reference Antibody (Tibulizumab), Target:BAFF&IL-17,Uniprot:Q9Y275&Q16552,Species:Human,isotype:IgG-scFv Anti-BAFF & IL-17A Reference Antibody (Tibulizumab), Target:BAFF&IL-17,Uniprot:Q9Y275&Q16552,Species:Human,isotype:IgG-scFv |
|||
| A998449 | Anti-Bcl-2 Reference Antibody (U.Toronto patent anti-Bax), Anti-Bcl-2 Reference Antibody (U.Toronto patent anti-Bax), |
|||
| A666776 | Anti-BCMA & BCMA & CD3 Reference Antibody (TNB-383B), Target:BCMA&BCMA&CD3,Uniprot:Q02223&Q02223&P07766,Species:Human,isotype:HalfIgG+ScFv Anti-BCMA & BCMA & CD3 Reference Antibody (TNB-383B), Target:BCMA&BCMA&CD3,Uniprot:Q02223&Q02223&P07766,Species:Human,isotype:HalfIgG+ScFv |
|||
| A666763 | Anti-BCMA & CD3 Reference Antibody (Alnuctamab), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:IgG-Fab Anti-BCMA & CD3 Reference Antibody (Alnuctamab), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:IgG-Fab |
|||
| A666782 | Anti-BCMA & CD3 Reference Antibody (Elranatamab), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:IgG-like Anti-BCMA & CD3 Reference Antibody (Elranatamab), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:IgG-like |
|||
| A666753 | Anti-BCMA & CD3 Reference Antibody (Emb-06), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:Fab-IgG Anti-BCMA & CD3 Reference Antibody (Emb-06), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:Fab-IgG |
|||
| A666773 | Anti-BCMA & CD3 Reference Antibody (Linvoseltamab), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:IgG-like Anti-BCMA & CD3 Reference Antibody (Linvoseltamab), Target:BCMA&CD3,Uniprot:Q02223&P07766,Species:Human,isotype:IgG-like |
|||
| A998450 | Anti-BST2 / CD317 Reference Antibody (SBI Biotech patent anti-BST2), Anti-BST2 / CD317 Reference Antibody (SBI Biotech patent anti-BST2), |
|||
| A998451 | Anti-BST2 / CD317 Reference Antibody (XmAb 5592), Anti-BST2 / CD317 Reference Antibody (XmAb 5592), |
|||
| A998452 | Anti-BTLA / CD272 Reference Antibody (icatolimab), Anti-BTLA / CD272 Reference Antibody (icatolimab), |
|||
| A998453 | Anti-BTN1A1 Reference Antibody (CTX-2026), Anti-BTN1A1 Reference Antibody (CTX-2026), |
|||
| A998575 | Anti-c-RET Reference Antibody (Regeneron patent anti-RET), Anti-c-RET Reference Antibody (Regeneron patent anti-RET), |
|||
| A998454 | Anti-C1q Reference Antibody (ANX005), Anti-C1q Reference Antibody (ANX005), |
|||
| A998455 | Anti-C1s Reference Antibody (sutimlimab), Anti-C1s Reference Antibody (sutimlimab), |
|||
| A666770 | Anti-C5 & Serum Albumin Reference Antibody (Gefurulimab), Target:C5&SerumAlbumin,Uniprot:P01031&P02768,Species:Human,isotype:VHH-VHH Anti-C5 & Serum Albumin Reference Antibody (Gefurulimab), Target:C5&SerumAlbumin,Uniprot:P01031&P02768,Species:Human,isotype:VHH-VHH |
|||
| A666729 | Anti-CA125 & CD3 Reference Antibody (Ubamatamab), Target:CA125&CD3,Uniprot:B5ME49&P07766,Species:Human,isotype:IgG-like Anti-CA125 & CD3 Reference Antibody (Ubamatamab), Target:CA125&CD3,Uniprot:B5ME49&P07766,Species:Human,isotype:IgG-like |
|||
| A998456 | Anti-CA9 / Carbonic anhydrase 9 Reference Antibody (girentuximab), Anti-CA9 / Carbonic anhydrase 9 Reference Antibody (girentuximab), |
|||
| A998457 | Anti-CALCA / CGRP Reference Antibody (eptinezumab), Anti-CALCA / CGRP Reference Antibody (eptinezumab), |
|||
| A998458 | Anti-CALCA / CGRP Reference Antibody (fremanezumab), Anti-CALCA / CGRP Reference Antibody (fremanezumab), |
